Articles citing this paper
Australia's pharmaceutical cost sharing policy: reducing waste or affordability?
Evan Doran and Jane Robertson
33(2) pp.231 - 240
7 articles found in Crossref database.
Keeping up with the Cadillacs: What Health Insurance Disparities, Moral Hazard, and the Cadillac Tax Mean to The Patient Protection and Affordable Care Act
Fletcher Rebecca Adkins
Medical Anthropology Quarterly. 2016 30(1). p.18
Pharmaceutical Benefits Scheme cost sharing, patient cost consciousness and prescription affordability
Doran Evan,
Robertson Jane, Salkeld Glenn
Australian Health Review. 2011 35(1). p.37
The affordability of prescription medicines in Australia: are copayments and safety net thresholds too high?
Searles Andrew,
Doran Evan,
Faunce Thomas A, Henry David
Australian Health Review. 2013 37(1). p.32
A systematic review of strategies used for controlling consumer moral hazard in health systems
Koohi Rostamkalaee Zohreh,
Jafari Mehdi, Gorji Hasan Abolghasem
BMC Health Services Research. 2022 22(1).
Policy options for pharmaceutical pricing and purchasing: issues for low- and middle-income countries
Nguyen Tuan Anh,
Knight Rosemary,
Roughead Elizabeth Ellen,
Brooks Geoffrey, Mant Andrea
Health Policy and Planning. 2015 30(2). p.267
Generic drug prices and policy in Australia: room for improvement? A comparative analysis with England
Mansfield Sarah J.
Australian Health Review. 2014 38(1). p.6
Patient access to medicines in two countries with similar health systems and differing medicines policies: Implications from a comprehensive literature review
Babar Zaheer- Ud-Din,
Gammie Todd,
Seyfoddin Ali,
Hasan Syed Shahzad, Curley Louise E.
Research in Social and Administrative Pharmacy. 2019 15(3). p.231
